Morrison & Foerster is proud to sponsor the ChinaBio® Partnering Forum to be held in Suzhou on May 23–24, 2012. This event will bring together more than 600 attendees from 24 countries around the world, including major pharmaceutical and biotech companies from the U.S. and Europe, China's leading biopharma and biotech companies, and researchers from universities and institutes throughout Asia interested in partnering and collaborations in China.
Dr. Janet Xiao, Partner, Patent and Life Sciences Groups, and Julian Thurston, Consultant, Global Life Sciences, will be speaking on "The Good, The Bad and The Ugly – Have you got what it takes to participate in the China life sciences market?"
Thurston is regarded as one of the top life sciences transactional attorneys in the UK and has more than 30 years of experience advising biotech companies on licensing, strategic partnering and other collaboration matters. Xiao has significant experience advising clients on IP management and strategic portfolio planning, patent prosecution and counseling, especially in the areas of biotechnology and pharmaceuticals.
This two-part session will first discuss some key drivers in successful life science deals in China, from "The Good" (things you need to take), to "The Bad" (things that hinder a deal), to "The Ugly" (things you need to leave at home). The second part of the session will take a closer look at assessing and valuing IP. The presentation will cover Western IP in China and how it is valued, to assessing the IP of a Chinese partner, what you are likely to see and what you should be looking for in your deal.
For more information about the ChinaBio® Partnering Forum, please visit the event website.